Clinical trial
Clinicopathological Analysis of Factors Associated With the Development of Adverse Events During Physical Therapy Intervention in Neurocritical Patients in the Intensive Care Unit
NCT07901140 is registered in ClinicalTrials.gov with Hospital H+ Queretaro as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinicopathological Analysis of Factors Associated With the Development of Adverse Events During Physical Therapy Intervention in Neurocritical Patients in the Intensive Care Unit
- Lead sponsor
- Hospital H+ Queretaro
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- September 23, 2026
- Completion date
- October 31, 2026
- Enrollment
- 47 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
brain injury, brain neoplasms, critical illness, orthostatic intolerance, stroke, subarachnoid hemorrhage
Arms
As registered; 2 arms.
-
Adverse Event Group
Adult neurocritical ICU patients who presented at least one adverse event (e.g., hypotension, hypertension, tachycardia, bradycardia, oxygen desaturation, increased ICP, decreased CPP, acute neurological deterioration) during the physical therapy intervention.
-
No Adverse Event Group
Adult neurocritical ICU patients who underwent physical therapy intervention without experiencing any adverse events during the session.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Incidence of Adverse Events During Physical Therapy
Presence or absence of any adverse event (binary variable: Yes/No) occurring during or immediately following a physical therapy session in adult neurocritical ICU patients. Adverse events include: hypotension (drop in SBP \> 20 mmHg), hypertension, tachycardia, bradycardia, oxygen desaturation, acute neurological deterioration, increase in intracranial pressure (ICP), or decrease in cerebral perfusion pressure (CPP) requiring therapy session suspension.
Lead sponsor's other trials
Hospital H+ Queretaro, most recent start first.
+7 more trials See the organization page
Similar trials
Same condition (Orthostatic Intolerance) and phase, most recent start first.
+11 more trials See the condition page